
Journal of Medicinal Chemistry p. 2163 - 2169 (1987)
Update date:2022-08-02
Topics:
Uno, Toshio
Takamatsu, Masanori
Inoue, Yoshimasa
Kawahata, Yoshihiro
Iuchi, Koji
Tsukamoto, Goro
A series of 6-fluoro- and 6,8-difluoro-7-(azole substituted)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids were prepared.Structure-activity relationship studies indicated that the antibacterial potency was better when the 6,8-substituents were fluorine atoms and the 7-substituent was either 1-imidazolyl, 20, or 4-methyl-1-imidazolyl, 25.From the results of studies on pharmacokinetic profile and toxicity, 20 and 25 were found to possess excellent antibacterial activities and to show high blood levels after oral administration to mice with low toxicity.
View MoreContact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Huangshan Honghui Pharm Technology Co., Ltd.(expird)
website:http://www.honghuichem.com
Contact:18855958372
Address:Qingshan Wan No.1,Nanyuan Kou,SheXian Huangshan City,Anhui Province
Arshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
hangzhou verychem science and technology co.ltd
website:http://www.verypharm.com
Contact:+86-571-88162785; 88162786
Address:F1502, 753 Shenhua road, Hangzhou, China
Doi:10.1016/S0277-5387(00)84643-4
(1984)Doi:10.1002/chem.200601022
(2007)Doi:10.1021/ol063097o
(2007)Doi:10.1002/hlca.19610440738
(1961)Doi:10.1055/s-0030-1261148
(2011)Doi:10.1002/jmr.2933
(2021)